Citations

Mayo Clinic

Clear

1575 citation(s) found for "Im, Gene".

Use of Viral Fusogenic Membrane Glycoproteins as Novel Therapeutic Transgenes in Gliomas
Bateman, Andrew, Johnson, K.A., Díaz, Rosa María, James, C. David , Vile, Richard G. , Galanis, Evanthia , Russell, Stephen J.

Human Gene Therapy | July 26, 2002 | Volume: 12 | Issue: 7 | Pages: 811-821

10.1089/104303401750148766 | PMID 11339897 Get It

Gene Transfer of Manganese Superoxide Dismutase Reverses Vascular Dysfunction in the Absence But Not in the Presence of Atherosclerotic Plaque
Zanetti, Michela , Sato, Junichi, Jost, Corey J., Gloviczki, Péter , Katušić, Zvonimir S. , O’Brien, Timothy , Gloviczki, Péter

Human Gene Therapy | July 26, 2002 | Volume: 12 | Issue: 11 | Pages: 1407-1416

10.1089/104303401750298562 | PMID 11485632 Get It

Genetic Modification of Human Trabecular Meshwork with Lentiviral Vectors
Loewen, Nils A. , Fautsch, Michael P. , Peretz, Mary, Bahler, Cindy K., Cameron, J. Douglas, Poeschla, Eric M. , Johnson, Douglas H.

Human Gene Therapy | July 26, 2002 | Volume: 12 | Issue: 17 | Pages: 2109-2119

10.1089/10430340152677449 | PMID 11747600 Get It

A Tissue-Engineered Stent for Cell-Based Vascular Gene Transfer
Panetta, Carmelo , Miyauchi, Katsumi , Simari, Robert D., Holmes, David R. , Schwartz, Robert S., Caplice, Noel M. , Berry, David

Human Gene Therapy | July 26, 2002 | Volume: 13 | Issue: 3 | Pages: 433-441

10.1089/10430340252792567 | PMID 11860710 Get It

A Hyperfusogenic Gibbon Ape Leukemia Envelope Glycoprotein: Targeting of a Cytotoxic Gene by Ligand Display
Chapel‐Fernandes, Sylvie , Chadwick, M P, Bullough, Frances J., Cosset, François‐Loïc , Fielding, Adele K. , Russell, Stephen J.

Human Gene Therapy | July 26, 2002 | Volume: 11 | Issue: 6 | Pages: 817-826

10.1089/10430340050015437 | PMID 10779159 Get It

Analysis of a complete homeobox gene repertoire: Implications for the evolution of diversity
Kappen, Claudia

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 97 | Issue: 9 | Pages: 4481-4486

10.1073/pnas.97.9.4481 | PMID 10781048 Get It

The completion of sequencing projects for various organisms has already advanced our insight into the evolution of entire genomes and the role of gene duplications. One multigene family that has served as a paradigm for the study of gene duplications and molecular evolution is the family of homeodomain-encoding genes. I present here an analysis of the homeodomain repertoire of an entire genome, that of the nematode Caenorhabditis elegans , in relation to our current knowledge of these genes in plants, arthropods, and mammals. A methodological framework is developed that proposes approaches for the analysis of homeodomain repertoires and multigene families in general.
Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease
Reiman, Eric M. , Caselli, Richard J. , Chen, Kewei , Alexander, Gene E. , Bandy, Daniel, Frost, Jennifer

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 98 | Issue: 6 | Pages: 3334-3339

10.1073/pnas.061509598 | PMID 11248079 Get It

Cross-sectional positron emission tomography (PET) studies find that cognitively normal carriers of the apolipoprotein E (APOE) ɛ4 allele, a common Alzheimer's susceptibility gene, have abnormally low measurements of the cerebral metabolic rate for glucose (CMRgl) in the same regions as patients with Alzheimer's dementia. In this article, we characterize longitudinal CMRgl declines in cognitively normal ɛ4 heterozygotes, estimate the power of PET to test the efficacy of treatments to attenuate these declines in 2 years, and consider how this paradigm could be used to efficiently test the potential of candidate therapies for the prevention of Alzheimer's disease. We studied 10 cognitively normal ɛ4 heterozygotes and 15 ɛ4 noncarriers 50–63 years of age with a reported family history of Alzheimer's dementia before and after an interval of approximately 2 years. The ɛ4 heterozygotes had significant CMRgl declines in the vicinity of temporal, posterior cingulate, and prefrontal cortex, basal forebrain, parahippocampal gyrus, and thalamus, and these declines were significantly greater than those in the ɛ4 noncarriers. In testing candidate primary prevention therapies, we estimate that between 50 and 115 cognitively normal ɛ4 heterozygotes are needed per active and placebo treatment group to detect a 25% attenuation in these CMRgl declines with 80% power and P = 0.005 in 2 years. Assuming these CMRgl declines are related to the predisposition to Alzheimer's dementia, this study provides a paradigm for testing the potential of treatments to prevent the disorder without having to study thousands of research subjects or wait many years to determine whether or when treated individuals develop symptoms.
Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.
Kovach, J. S., Hartmann, Arndt, Blaszyk, Hagen, Cunningham, Julie M. , Schaid, Daniel J. , Sommer, Steve S.

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 93 | Issue: 3 | Pages: 1093-1096

10.1073/pnas.93.3.1093 | PMID 8577720 Get It

Human cancer cells with a mutated p53 tumor-suppressor gene have a selective growth advantage and may exhibit resistance to ionizing radiation and certain chemotherapeutic agents. To examine the prognostic value of mutations in the p53 gene, a cohort of 90 Midwestern Caucasian breast cancer patients were analyzed with methodology that detects virtually 100% of all mutations. The presence of a p53 gene mutation was by far the single most predictive indicator for recurrence and death (relative risks of 4.7 and 23.2, respectively). Direct detection of p53 mutations had substantially greater prognostic value than immunohistochemical detection of p53 overexpression. Analysis of p53 gene mutations may permit identification of a subset of breast cancer patients who, despite lack of conventional indicators of poor prognosis, are at high risk of early recurrence and death.
Evidence for regulation of cartilage differentiation by the homeobox gene Hoxc-8
Yueh, Y. Gloria, Gardner, David P., Kappen, Claudia

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 95 | Issue: 17 | Pages: 9956-9961

10.1073/pnas.95.17.9956 | PMID 9707582 Get It

Homeobox genes of the Hox class are required for proper patterning of skeletal elements, but how they regulate the differentiation of specific tissues is unclear. We show here that overexpression of a Hoxc-8 transgene causes cartilage defects whose severity depends on transgene dosage. The abnormal cartilage is characterized by an accumulation of proliferating chondrocytes and reduced maturation. Since Hoxc-8 is normally expressed in chondrocytes, these results suggest that Hoxc-8 continues to regulate skeletal development well beyond pattern formation in a tissue-specific manner, presumably by controlling the progression of cells along the chondrocyte differentiation pathway. The comparison to Hoxd-4 and Isl-1 indicates that this role in chondrogenesis is specific to proteins of the Hox class. Their capacity for regulation of cartilage differentiation suggests that Hox genes could also be involved in human chondrodysplasias or other cartilage disorders.
Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation
Rinaldo, Piero, Rhead, William J., Tian, Liqun, Millington, David S., Vockley, Jerry , Hamm, Doug A., Brix, Amy E., Lindsey, J. Russell, Pinkert, Carl A. , O’Brien, William E., Kurtz, David M. , Wood, Philip A.

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 95 | Issue: 26 | Pages: 15592-15597

10.1073/pnas.95.26.15592 | PMID 9861014 Get It

Abnormalities of fatty acid metabolism are recognized to play a significant role in human disease, but the mechanisms remain poorly understood. Long-chain acyl-CoA dehydrogenase (LCAD) catalyzes the initial step in mitochondrial fatty acid oxidation (FAO). We produced a mouse model of LCAD deficiency with severely impaired FAO. Matings between LCAD +/− mice yielded an abnormally low number of LCAD +/− and −/− offspring, indicating frequent gestational loss. LCAD −/− mice that reached birth appeared normal, but had severely reduced fasting tolerance with hepatic and cardiac lipidosis, hypoglycemia, elevated serum free fatty acids, and nonketotic dicarboxylic aciduria. Approximately 10% of adult LCAD −/− males developed cardiomyopathy, and sudden death was observed in 4 of 75 LCAD −/− mice. These results demonstrate the crucial roles of mitochondrial FAO and LCAD in vivo .